C. Berthou

Statistics

Publications

Citations

209

H-Index

Active since

1991

Affiliations

Centre Hospitalier Universitaire de Tours(Current)

Centre Hospitalier Régional et Universitaire de Nancy

C. Berthou is an author at Centre Hospitalier Universitaire de Tours specializing in chemotherapy, hematologic malignancy therapy, and acute myeloid leukemia treatment.

Publications per year

1991–2020

Publications

A placebo-controlled study of recombinant human granulocyte-macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).

Francis Witz, Alain Sadoun, M. C. Perrin et al. · PubMed · 1998 · 147 citations

Medicine, Hematology, Pharmacology +10

Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial

Mathilde Hunault, Malgorzata Truchan-Graczyk, D. Caillot et al. · Haematologica · 2007 · 31 citations · Full text

Medicine, Hematology, Oncology +15

Treatment of acute myelogenous leukaemia in patients aged 50–65: idarubicin is more effective than zorubicin for remission induction and prolonged disease‐free survival can be obtained using a unique consolidation course

B. Pignon, F Witz, B Desablens et al. · British Journal of Haematology · 1996 · 11 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

[Pearson's syndrome. Pancytopenia with exocrine pancreatic insufficiency: new mitochondrial disease in the first childhood].

Cormier, Agnès Rötig, Jean‐Paul Bonnefont et al. · PubMed · 1991 · 10 citations

Life Sciences, Genetics, Molecular Genetics +17

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laëtitia Largeaud, Pascale Cornillet‐Lefèbvre, Jean‐François Hamel et al. · Leukemia · 2020 · 10 citations · Full text

Pharmacy, Geriatric Medicine, Pharmacotherapy +4

1–5 of 5